Contents
-
news
-
Health
What is a new non-opioid pain reliever approved by FDA in decades, Zernwax?
The US Food and Drug Administration has approved Jernvax, also known as Sujatrigin 50 mg oral pills-a first-in-in-in-opioid analgesic to behave moderately for severe acute pain in yasks. Journavx reduces pain by targeting pain in which the pain signal includes sodium channels in the peripheral nervous system before reaching the brain. Read on to know more.
Journavx composition is completely different from opioids, which binds receptors in your brain
The US Food and Drug Administration approved a new type of pain reliever that has no risk of addiction or overdose, which is usually associated with opioid drugs. Medicine, SuzetriginSelling under the brand name is a new class of pain approved in more than two decades.
“Today’s approval is an important public health milestone Acute pain management“Jacqueline Korigan-Kureche, Acting Director of FDA’s Center for Drug Evolution and Research, said.” A new non-opioid analgesic medical class for acute pain provided opportunity to reduce some risks related to using an opioid for pain Does and provides another treatment option to patients. ”
Manufactured by vertex pharmaceuticals, Jernvax will help in medium to moderate to severe acute pain in adults. Acute pain is short -term pain that is often caused by surgery, accident or injury.
“With the approval of Jurnavx, a non-opioid pain indicator inhibitor and the first new class of the drug approved in more than 20 years, we have the opportunity to change the paradigm of acute pain management and establish a new standard of care, “Reshma Kewalmani, CEO and President of Wartax said.
Why is the approval of Jernvax important?
According to experts, it is considered a success in the treatment of severe pain without opioid drugs such as Vikodin and Oxicopt. Opioids work in the brain To produce various types of effects including pain relief but in the long run Can cause severe addictionOpioid use is known as a disorder (OUD). Many people use opioid due to enthusiasm or “high”.
Federal figures say more than 81,000 people died in 2023, which included opioids.
How does Jernvax work?
The FDA says that Journavx “The inclusion of sodium channels in the signs of pain reduces the pain by targeting the pain-signing passage, causing the pain sign before reaching the brain.” This composition is completely different from opioid, which binds receptors in your brain that receives nerve signals from your body.
According to the FDA, Jernvax showed “statistically significant decrease in pain” in two random tests of acute surgical pain. However, it did not improve a normal opioid-acetaminophen combination pill.
However, experts say that the benefit of the drug is higher than its efficacy, including side effects, including the absence of intoxication.
At what cost will Jurnavx be available?
Journavx list price is $ 15.50 per pill, much more expensive than comparable opioids. However, it is not clear to what extent the insurers can cover the drug, and patient support programs are available for Zernavax.
Now get the latest news with health and braking news and top headlines worldwide.
Suzetrigin
Acute pain management
Opioids work in the brain
Can cause severe addiction